Enjaymo 1,100 mg/22 mL (50 mg/mL) injection Images
Generic Name: sutimlimab
This medication has been identified as Enjaymo 1,100 mg/22 mL (50 mg/mL) injection. It is supplied by Bioverativ U.S. LLC.
Enjaymo is used in the treatment of Cold Agglutinin Disease and belongs to the drug class selective immunosuppressants. Enjaymo 1,100 mg/22 mL (50 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Enjaymo
- Generic Name
- sutimlimab
- Strength
- 1,100 mg/22 mL (50 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bioverativ U.S. LLC
- National Drug Code (NDC)
- 80203-0347
More about Enjaymo (sutimlimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
